Growth Metrics

908 Devices (MASS) Divestments (2025)

908 Devices (MASS) reported Divestments of -$8000.0 for Q3 2025, down 100.01% on a QoQ basis from $69.9 million in Q1 2025.

908 Devices (MASS) has 1 years of Divestments data on file, last reported at -$8000.0 in Q3 2025.

  • Quarterly Divestments changed N/A year-over-year to -$8000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $69.9 million (changed N/A YoY) and the FY2025 annual result came in at $69.9 million, changed N/A from the prior year.
  • Divestments retreated to -$8000.0 in Q3 2025 per MASS's latest filing, from $69.9 million in the prior quarter.
  • Across five years, Divestments topped out at $69.9 million in Q1 2025 and bottomed at -$8000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -8,000.00
Mar 31, 2025 69.92 Mn